Skip to main content

Table 1 Characteristics of 74 NSCLC patients with postoperative locoregional recurrence treated with radical radiotherapy

From: Survival and prognostic factors of non-small cell lung cancer patients with postoperative locoregional recurrence treated with radical radiotherapy

Characteristic

Number of patients (%)

Sex

 Male

54 (73.0)

 Female

20 (27.0)

Stage of primary tumora

 I

17 (23.0)

 II

16 (21.6)

 III

34 (45.9)

 Unknown

7 (9.5)

Histology

 Squamous cell carcinoma

18 (24.3)

 Adenocarcinoma

41 (55.4)

 Lymphoepithelioma-like carcinoma

10 (13.3)

 Others

5 (6.8)

EGFR status

 Mutation

14 (18.9)

 Wild-type

37 (50.0)

 Unknown

23 (31.1)

Recurrence site

 Stump

8 (10.8)

 Regional lymph nodes

56 (75.7)

 Ipsilateral lung

6 (8.1)

 Both stump and regional lymph nodes

3 (4.0)

 Both regional lymph nodes and ipsilateral lung

1 (1.4)

Concurrent chemotherapy

 Yes

59 (79.7)

 No

15 (20.3)

Radiation technique

 3D-CRT

5 (6.8)

 IMRT

62 (83.8)

 SBRT

7 (9.4)

  1. NSCLC non-small cell lung cancer, EGFR epidermal growth factor receptor, 3D-CRT 3-dimensional conformal radiotherapy, IMRT intensity-modulated radiotherapy, SBRT stereotactic body radiotherapy
  2. aThe 7th edition of the American Joint Committee on Cancer (AJCC) staging system was used